Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for abt 737
Most Correlated Studies
- L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
- Small cell lung cancer cell line profiling based on the response to the BCL2 inhibitor ABT-737
- Mantle cell lymphoma cell lines sensitive or resistant to the BH3 mimetic ABT-737
- L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
- L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
Most Relevant Literature
- ABT-737, a BH3 Mimetic, Enhances the Therapeutic Effects of Ionizing Radiation in K-ras Mutant Non-S…
- Comparison of putative BH3 mimetics AT-101, HA14-1, sabutoclax and TW-37 with ABT-737 in platelets.
- Differentiation of acute myeloid leukemia (AML) cells with ATRA reduces 18F-FDG uptake and increases…
- ML355 Modulates Platelet Activation and Prevents ABT-737 Induced Apoptosis in Platelets.
- Curcumin at Low Doses Potentiates and at High Doses Inhibits ABT-737-Induced Platelet Apoptosis.
Most Relevant Clinical Trials
- Ex Vivo Evaluation of the Interest of the Association of Platinum With a Molecule BH3-mimetic ABT-73…
- A Phase 2a Study Evaluating the Safety and Efficacy of ABT-981 in Patients With Erosive Hand Osteoar…
- Studying Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
- Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease
- ABT-751 in Treating Young Patients With Refractory Solid Tumors
